Investor Webinar – 3pm AEST Tuesday 2 July
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused...
Successful Maiden Dosing of TRP-8803 (IV-Infused Psilocin) Completed in Global First
Tryptamine Therapeutics Limited (‘Tryp’ or the ‘Company’) (ASX: TYP),...
Investor Webinar – 3pm AEST Tuesday 2 July
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals...
Strategy for Cuban Mining Joint Venture
Antilles Gold Limited (“Antilles Gold” or the “Company”) (ASX: AAU, OTCQB: ANTMF) is pleased to advise that on 28...
Successful Maiden Dosing of TRP-8803 (IV-Infused Psilocin) Completed in Global First
Tryptamine Therapeutics Limited (‘Tryp’ or the ‘Company’) (ASX: TYP), a clinical-stage biotechnology company focused...